Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1958 1
1968 1
1969 1
1970 2
1971 1
1973 1
1974 2
1975 3
1976 3
1978 1
1979 1
1980 1
1981 1
1982 4
1983 3
1985 3
1987 3
1988 12
1989 8
1990 3
1991 4
1992 7
1993 6
1994 1
1995 5
1996 9
1997 4
1998 5
1999 5
2000 8
2001 4
2002 9
2003 5
2004 1
2005 2
2006 4
2007 3
2008 2
2011 1
2012 1
2013 1
2015 1
2016 4
2017 4
2018 5
2019 4
2020 3
2021 2
2022 6
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Results by year

Filters applied: . Clear all
Page 1
Combined use of nivolumab and ipilimumab in Japanese patients with melanoma: a multicentre retrospective study of 111 cases.
Fujisawa Y, Namikawa K, Yoshino K, Kiniwa Y, Ito T, Kato H, Matsushita S, Hoashi T, Nakamura Y, Yoshikawa S, Miyagawa T, Asai J, Matsuya T, Fukushima S, Kato J, Takenouchi T, Uchi H, Masuzawa M, Yanagi T, Maekawa T. Fujisawa Y, et al. Among authors: matsuya t. Br J Dermatol. 2023 Jul 17;189(2):223-250. doi: 10.1093/bjd/ljad114. Br J Dermatol. 2023. PMID: 37017027 No abstract available.
Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients.
Nakamura Y, Namikawa K, Kiniwa Y, Kato H, Yamasaki O, Yoshikawa S, Maekawa T, Matsushita S, Takenouchi T, Inozume T, Nakai Y, Fukushima S, Saito S, Otsuka A, Fujimoto N, Isei T, Baba N, Matsuya T, Tanaka R, Kaneko T, Onishi M, Kuwatsuka Y, Nagase K, Onuma T, Nomura M, Umeda Y, Yamazaki N. Nakamura Y, et al. Among authors: matsuya t. Eur J Cancer. 2022 Nov;176:78-87. doi: 10.1016/j.ejca.2022.08.030. Epub 2022 Oct 1. Eur J Cancer. 2022. PMID: 36194906
Systemic therapy for Asian patients with advanced BRAF V600-mutant melanoma in a real-world setting: A multi-center retrospective study in Japan (B-CHECK-RWD study).
Namikawa K, Ito T, Yoshikawa S, Yoshino K, Kiniwa Y, Ohe S, Isei T, Takenouchi T, Kato H, Mizuhashi S, Fukushima S, Yamamoto Y, Inozume T, Fujisawa Y, Yamasaki O, Nakamura Y, Asai J, Maekawa T, Funakoshi T, Matsushita S, Nakano E, Oashi K, Kato J, Uhara H, Miyagawa T, Uchi H, Hatta N, Tsutsui K, Maeda T, Matsuya T, Yanagisawa H, Muto I, Okumura M, Ogata D, Yamazaki N. Namikawa K, et al. Among authors: matsuya t. Cancer Med. 2023 Sep;12(17):17967-17980. doi: 10.1002/cam4.6438. Epub 2023 Aug 16. Cancer Med. 2023. PMID: 37584204 Free PMC article.
Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patients.
Mori T, Namikawa K, Yamazaki N, Kiniwa Y, Yamasaki O, Yoshikawa S, Inozume T, Kato H, Nakai Y, Fukushima S, Takenouchi T, Maekawa T, Matsushita S, Otsuka A, Nomura M, Baba N, Isei T, Saito S, Fujimoto N, Tanaka R, Kaneko T, Kuwatsuka Y, Matsuya T, Nagase K, Onishi M, Onuma T, Nakamura Y. Mori T, et al. Among authors: matsuya t. Front Med (Lausanne). 2023 Aug 10;10:1229937. doi: 10.3389/fmed.2023.1229937. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37636577 Free PMC article.
Severe immune checkpoint inhibitor-associated gastritis: A case series and literature review.
Sugiyama Y, Tanabe H, Matsuya T, Kobayashi Y, Murakami Y, Sasaki T, Kunogi T, Takahashi K, Ando K, Ueno N, Kashima S, Moriichi K, Tanino M, Mizukami Y, Fujiya M, Okumura T. Sugiyama Y, et al. Among authors: matsuya t. Endosc Int Open. 2022 Jul 15;10(7):E982-E989. doi: 10.1055/a-1839-4303. eCollection 2022 Jul. Endosc Int Open. 2022. PMID: 35845030 Free PMC article.
A new antibiotic, kinamycin.
Itŏ S, Matsuya T, Omura S, Otani M, Nakagawa A. Itŏ S, et al. Among authors: matsuya t. J Antibiot (Tokyo). 1970 Jun;23(6):315-7. doi: 10.7164/antibiotics.23.315. J Antibiot (Tokyo). 1970. PMID: 5458310 Free article. No abstract available.
Intraductal carcinoma of the tongue. Report of a case.
Watatani K, Shirasuna K, Aikawa T, Matsuya T. Watatani K, et al. Among authors: matsuya t. Int J Oral Maxillofac Surg. 1991 Jun;20(3):175-6. doi: 10.1016/s0901-5027(05)80011-6. Int J Oral Maxillofac Surg. 1991. PMID: 1653810 Review.
Narrower clinical margin in high or very high-risk squamous cell carcinoma: a retrospective, multicenter study of 1,000 patients.
Baba N, Kato H, Nakamura M, Matsushita S, Aoki M, Fujimoto N, Kato T, Iino S, Saito S, Yasuda M, Asai J, Ishikawa M, Yatsushiro H, Kawahara Y, Matsuya T, Araki R, Teramoto Y, Hasegawa M, Tokunaga T, Nakamura Y. Baba N, et al. Among authors: matsuya t. J Dtsch Dermatol Ges. 2022 Aug;20(8):1088-1099. doi: 10.1111/ddg.14810. Epub 2022 Aug 4. J Dtsch Dermatol Ges. 2022. PMID: 35927033
172 results